TAK-285
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
TAK-285
Description :
TAK-285 is a novel dual HER2 and EGFR (HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1.Stability :
≥ 2 yearsPurity :
>98% (HPLC)Weight :
547.96Molecular Formula :
C26H25ClF3N5O3Notes :
Research use only, not for human use.Receptor :
Aurora B| EGFR/HER1| HER2| HER4| MEK1CAS Number :
871026-44-7
